RARE icon

Ultragenyx Pharmaceutical
RARE

Overview Fund Activity

172 hedge funds and large institutions have $2.79B invested in Ultragenyx Pharmaceutical in 2016 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 67 increasing their positions, 56 reducing their positions, and 15 closing their positions.

Holders
172
Holders Change
+11
Holders Change %
+6.83%
% of All Funds
4.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
27
Increased
67
Reduced
56
Closed
15
Calls
$14.3M
Puts
$6.15M
Net Calls
+$8.14M
Net Calls Change
+$9.02M

Top Buyers

1
CGT
1
Capital Guardian Trust
California
$35M
2
Capital International Investors
2
Capital International Investors
California
$34.1M
3
CWAM
3
Columbia Wanger Asset Management
Illinois
$89.2M
4
EA
4
Emerald Advisers
Pennsylvania
$19.2M
5
EMFAT
5
Emerald Mutual Fund Advisers Trust
Pennsylvania
$18.8M

Top Sellers

1
Wells Fargo
1
Wells Fargo
California
$52.2M
2
Millennium Management
2
Millennium Management
New York
$709K
3
Lord, Abbett & Co
3
Lord, Abbett & Co
New Jersey
$11.2M
4
Ameriprise
4
Ameriprise
Minnesota
$12.3M
5
WC
5
Weatherbie Capital
Massachusetts
$16.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
$20M +$1.29M +18,212 +7%
Brown Advisory
27
Brown Advisory
Maryland
$20M +$1.4M +19,790 +8%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$19.5M +$782K +11,018 +4%
EA
29
Emerald Advisers
Pennsylvania
$19.2M +$19.2M +269,983 New
EMFAT
30
Emerald Mutual Fund Advisers Trust
Pennsylvania
$18.8M +$18.8M +264,546 New
PC
31
Polar Capital
United Kingdom
$17.1M +$16.8M +236,803 +4,816%
Axa
32
Axa
France
$16.6M +$451K +6,356 +3%
WC
33
Weatherbie Capital
Massachusetts
$16.4M -$7.6M -107,160 -32%
Deutsche Bank
34
Deutsche Bank
Germany
$15.2M +$3.96M +55,799 +35%
Charles Schwab
35
Charles Schwab
California
$13.1M +$965K +13,606 +8%
Ameriprise
36
Ameriprise
Minnesota
$12.3M -$12.4M -175,434 -50%
TA
37
Teachers Advisors
New York
$12.3M +$36.2K +510 +0.3%
O
38
OrbiMed
New York
$12M – – –
Bank of New York Mellon
39
Bank of New York Mellon
New York
$11.7M -$465K -6,560 -4%
CCI
40
Columbus Circle Investors
$11.6M -$1.62M -22,784 -12%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$11.5M +$2.01M +28,314 +21%
Lord, Abbett & Co
42
Lord, Abbett & Co
New Jersey
$11.2M -$12.8M -179,977 -53%
CI
43
Capital International
California
$11.1M +$11.1M +157,000 New
Invesco
44
Invesco
Georgia
$11.1M +$11.1M +156,924 New
BIM
45
BlackRock Investment Management
Delaware
$10.9M +$60K +846 +0.6%
RSCM
46
Rock Springs Capital Management
Maryland
$10.4M +$390K +5,500 +4%
CS
47
Credit Suisse
Switzerland
$8.47M -$1.55M -21,811 -15%
CAM
48
Cormorant Asset Management
Massachusetts
$7.86M – – –
HRCM
49
Hood River Capital Management
Florida
$7.82M +$7.82M +110,291 New
BBA
50
Baker Bros. Advisors
New York
$7.09M -$773K -10,894 -10%
1
2
3 4 5